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Countries, states, and island nations often need forward planning of their radiotherapy ser-
vices driven by different motives. Countries without radiotherapy services sponsor patients
to receive radiotherapy abroad. They often engage professionals for a feasibility study in
order to establish whether it would be more cost-beneficial to establish a radiotherapy facil-
ity. Countries where radiotherapy services have developed without any central planning,
find themselves in situations where many of the available centers are private and thus
inaccessible for a majority of patients with limited resources. Government may decide
to plan ahead when a significant exodus of cancer patients travel to another country for
treatment, thus exposing the failure of the country to provide this medical service for its
citizens. In developed countries, the trigger has been the existence of highly visible waiting
lists for radiotherapy revealing a shortage of radiotherapy equipment. This paper suggests
that there should be a systematic and comprehensive process of long-term planning of
radiotherapy services at the national level, taking into account the regulatory infrastructure
for radiation protection, planning of centers, equipment, staff, education programs, quality
assurance, and sustainability aspects. Realistic budgetary and cost considerations must
also be part of the project proposal or business plan.
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INTRODUCTION
The contribution of radiotherapy to cancer treatment is signifi-
cant. Radiotherapy represents one of the three pillars of cancer
treatment (with surgery and systemic therapies) and in multiple
studies has proven to be a cost-effective modality for cure and
palliation. The impact of radiotherapy in cancer cure has been
estimated at 40%, compared to 49% of patients being cured by
surgery, and 11% of patients by systemic treatments (1).
OBJECTIVE AND CONTEXT
The objective of radiotherapy services is the delivery of an ade-
quate radiotherapy treatment to all patients who need it, within
a culture of safety awareness. The optimal yield of radiotherapy
services occurs when they are integrated into effective healthcare
systems and functional national cancer control plans. The reason is
simple. In countries without a coordinated national cancer control
plan, cancer patients are treated when they are diagnosed, often
presenting in advanced stages of disease. This in turn determines
that the majority of patients are treated for palliation.
In countries or states with an effective national cancer con-
trol plan that includes preventive, early detection, and screening
programs, an increased number of patients are diagnosed at an
early disease stage, treated effectively, and therefore the treatment
outcomes of radiotherapy improve (Figure 1).
SAFETY FIRST
Government plays a central role in the establishment of norma-
tive and regulation of the use of radiation in medicine, which
needs to be satisfied before introducing radiotherapy into a coun-
try. Meeting the regulatory requirements will go toward satisfy-
ing the radiation protection and safety aspects of establishing
radiotherapy services. The range of regulatory requirements varies
from country to country, but the IAEA has established, through
the provision of safety standards (2), the essential components of
a required regulatory infrastructure for radiation protection and
safety. Regulations for the use of ionizing radiation in medicine
are established in respect of the governmental, legal and regula-
tory framework for safety. The objective is to protect the public
health and safety by preventing the availability of unsafe prac-
tices and equipment. Radiation exposure of human beings should
only be considered when it is effective and potentially beneficial
for diagnosis or treatment. Needless or excessive exposures are
not justified and patients should be guaranteed that the treat-
ment is reliable and that individuals administering radiotherapy
are adequately trained.
Safety is the primary regulatory goal. Excessive or non-existing
regulations can prohibit access to radiotherapy. A country’s reg-
ulatory infrastructure needs to be in place in order to balance
safety, effectiveness, the need for medical radiation practices,
and access to therapy. Regulations must be in place to facilitate
informed and rational decision-making and to protect against
unwise, ill-informed, or negligent practices.
Dunscombe (3) made an analysis of seven sources of radio-
therapy safety recommendations and distilled from them the 12
most frequently recommended initiatives. The 12 recommended
initiatives were: (1) staff training, (2) adequate staffing levels,
(3) adequate documentation/standard operating procedures, (4)
voluntary incident learning system, (5) quality communication,
(6) use of check lists, (7) quality control and preventive main-
tenance, (8) dosimetric audits, (9) radiation oncology specific
accreditation, (10) minimizing interruptions, (11) prospective risk
assessment, and (12) a safety culture.
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FIGURE 1 | Estimation of radiotherapy needs coverage worldwide. The colors indicate the estimated coverage of the need by existing radiotherapy
equipment. Source of data: Refs. (24) and (25).
ESTIMATING DEMAND
How many teletherapy machines should be operational in a coun-
try in order to completely cover demand? This is a challenging
question since there are large variations in radiotherapy utiliza-
tion (RTU) among countries. In this discussion, we use the term
teletherapy machine to refer to all including cobalt-60 units,
medical accelerators, helical tomotherapy devices, and robotic
radiotherapy. RTU benchmarks can be derived from evidence-
based guidelines, criterion based, or based on a retrospective
examination of actual practice.
Estimating demand means knowing how many patients will
require a radiotherapy course in any given year or better yet how
many courses of radiotherapy will be given since some patients
may require more than one course. A more refined method con-
sists in estimating the number of fractions that will be applied
based on the cancer spectrum of diseases and stages. The num-
ber of new cancer cases per year in a given population (crude
incidence) can be obtained from a national population based
cancer registry in countries that have a reliable operational one.
For countries where this variable is not measured, the Interna-
tional Agency for the Research on Cancer (IARC) provides a best
estimate of crude incidence, which is reflected in their database
Globocan-2012 (8).
Only a fraction of all cancer patients will require radiotherapy,
which leads to the concept of RTU rate. Approximately, 48–62%
of all cancer patients’ benefit from radiation therapy (9–11). This
depends on the extent of disease at presentation and the pro-
files of cancer observed in a specific population. A RTU of 50%
would then be a good approximation to this value for developed
and middle-income countries. There is no evidence-based data for
low-income countries. The total number of teletherapy machines
required in a given country is given by the total number of “radio-
therapy courses” in a year, divided by the teletherapy machine
use. The teletherapy machine use is the number of radiother-
apy courses delivered by one teletherapy machine in 1 year. The
ESTRO/QUARTS Project (12) estimated a teletherapy machine
use of 450 courses/year at that time. This benchmark is ques-
tioned today since the radiotherapy practice has changed signifi-
cantly with the introduction of new technologies and fractionation
schedules. However, an alternate benchmark that reflects current
practice has not been determined so far. A more sophisticated
approach to demand calculation can be attempted taking into
account the full spectrum of diseases and their stages in a particu-
lar country, and the proportion of patients that will require IMRT
techniques and its variations as opposed to 2D or 3D conformal
techniques.
Data from Australia (13) indicates that a curative course of
radiotherapy requires an average of 22 fractions and a palliative
course four fractions, thus the total average would be 18 fractions
per first course. The average linear accelerator treats four to five
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patients per hour, so the total linac utilization will depend on
the total number of hours per day that the machine is active. In
Canada, the average time of machine operation per day is 10 h.
RADIOTHERAPY CENTERS
A radiotherapy center is a medical department where patients
are treated with usually megavoltage radiotherapy. The defini-
tion is not redundant. Centers that use orthovoltage only for skin
lesions, radiosurgery only for intracranial disease, brachytherapy
only or radiotherapy for veterinarian applications are not con-
sidered radiotherapy centers. International regulations on safety
require that treatments with ionizing radiation be prescribed by a
physician trained and licensed in this discipline and the dosimetry
monitored by a trained medical physicist.
Radiotherapy centers location should follow the population
concentration distribution in a country. A single center may suf-
fice in small countries or even in large countries with a small
population if transport services between population centers are
adequate. The centralized comprehensive facility model may be
adequate when the distances involved are short, but for longer
distances, a fully decentralized service is warranted (14).
In large countries, a network of oncology services will be
required, with a radiotherapy center within each region. For those
patients, living at a distance from the radiotherapy center, fund-
ing will have to be set aside to cover for costs of transport and
accommodation facilities, in particular for pediatric patients and
their families. Countries where a significant proportion of the
population are living at a distance or geographically isolated from
the main centers, may also consider either the implementation of
consultation clinics as focal points for further referral (primary
care clinics can fulfill this role) or alternatively facilitate patient
commuting through an organized transport service.
A study from Ontario (11) showed that the province’s highly
centralized radiotherapy network did not provide adequate or
equitable access to care to the province’s dispersed population.
In this study, the actual RTU rate was 29%, which is lower than the
generally accepted rate for a developed country. A similar study
from the North of England showed socio-economic gradients in
access to services (15) related to education levels and car use.
A radiotherapy center or department should be specifically
planned and designed to fulfill its role, in terms of appropriate
patient flow, location of the treatment machines, waiting rooms,
physicians’ offices, and patient examination rooms, planning
rooms, mold room, storage, and others as required.
Once the decision to establish a radiotherapy facility has been
made, careful co-ordination, and monitoring of the planning and
timelines is key to the project’s success. The professional team
required to design, construct, and commission a radiotherapy
facility needs to be multi-disciplinary because the project not
only involves the construction of specialized bunkers to house the
radiotherapy imaging and treatment equipment but also needs
to take into account the clinical workflow as well as anticipate
non-disruptive expansion in the future. Since the process of
radiotherapy is closely related to key staff functions, the detail
of the internal design of the facility is important to achiev-
ing sound work-place ergonomics and to facilitate workflow. An
overall concept design should therefore consist of the five key
functional areas, which expedite radiotherapy workflow. These
functional areas are the reception, clinical consulting areas, the
imaging and treatment planning area, and the treatment suites
(teletherapy and brachytherapy). The relative placement of these
areas should be adapted to the proposed site and preferred local
practice; however, it should expedite broader staff and patient
movement, consultation, and communication. The position of
the major equipment at the various duty stations within each
functional area is provided for in “International Atomic Energy
Agency (IAEA) Radiotherapy facilities; master planning and con-
cept design considerations (16)”. Expansion route possibilities are
also indicated.
Clinically qualified medical physicists are responsible for ensur-
ing that the shielding calculations are based on acceptable esti-
mates of the projected local workload, use, and occupancy factors,
and that the design accommodates the desired clinical workflow.
In addition, the future implementation of new techniques and
technologies should also be considered. The national radiation
safety regulator is mandated to approve the final design prior
to construction, and license the facility prior to the initiation of
operations. Timeline synchronization between building a radio-
therapy facility, procurement, and installation of equipment and
training of staff is very important and has to be planned care-
fully. If the equipment is installed but the team has not completed
their training, the result will be a non-operational facility, which
is generating costs but not treating patients. Conversely, if staff
completes their training long before the facility is ready, members
may be compelled to take other job positions, change career, or
emigrate in search of their livelihood. Our experience indicates
that training of a radiotherapy team should start roughly 2 years
before the initiation of construction. Funds for staff training must
be allocated early and be part of the initial business plan or project
proposal.
EQUIPMENT
A basic radiotherapy center aiming at treating an average of 1000
patients/year should be equipped with at least a single-photon
energy teletherapy unit, an orthovoltage unit, a brachytherapy
afterloader (ideally for high dose-rate brachytherapy), an X-ray
C-arm, full range of applicators, a simulator, preferably a CT-
simulator, a computerized treatment planning system (TPS), film
processing equipment, patient immobilization devices, and mold
room equipment, beam measurement and quality assurance (QA)
equipment. A second teletherapy unit may become necessary to
expedite workflow and for back-up.
Procurement of new equipment has to be implemented
through a transparent tendering process. Since technological
developments in radiotherapy occur much faster than the eco-
nomic lifetime of a linear accelerator, larger radiotherapy centers,
which replace one or more machines every few years, enable the
introduction of new technology at a faster rate.
The cost and cost-benefit of radiotherapy has been extensively
studied. The cost of radiotherapy in a given facility tends to rise as
the number of treated patients decreases below 1600, and extended
hours of operation do not appear to generate significant, if any,
savings when realistic assumptions about machine lifetime and
overtime payments are made (17).
www.frontiersin.org November 2014 | Volume 4 | Article 315 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rosenblatt Planning national radiotherapy services
STAFFING AND EDUCATION
A very important consideration is staffing levels. There is very
little evidence-based documentation that precisely quantifies the
number and type of professionals needed to support a service
that is also directly related to patient workload, technology, tech-
niques, procedures, and infrastructure. As a result, initiation of
new radiotherapy services in low and middle-income countries
has traditionally been planned in accordance with IAEA guide-
lines, which list a suite of equipment constituting a basic service
that is resourced by a core number of professionals who attend to
a given patient workload (18, 19). These professionals, including
radiation oncologists and medical physicists, are required in the
practice of radiotherapy under the IAEA International Basic Safety
Standards (2).
The aforementioned basic department should have four to
five radiation oncologists, three to four medical physicists, seven
RTTs, three radiotherapy nurses, and one maintenance techni-
cian/engineer. Staff numbers and training should be adapted to the
number of patients treated, the case-mix, the number of courses
given per year, the activities performed and the level of com-
plexity of the equipment and techniques. Staffing requirements
vary greatly depending on case-mix, type, and complexity of the
techniques, research, and teaching commitments. Given the com-
plexities of today’s modern radiotherapy clinics, rather than give
fixed recommendations for staff numbers, the current approach is
to use an algorithm that will provide the number of staffs needed
for a department according to the activities implemented.
Staffing levels in the clinical environment are not only impor-
tant for planning and budgetary purposes and fundamental to
quality patient care and safety but they are often also specified
for practice accreditation purposes and professional credentialing.
The estimation of reasonable staffing levels to support radio-
therapy services has often been loosely based on patient pop-
ulation size, infrastructure, equipment availability, and disease
incidence. Retrospective subjective estimates based on existing
practice are often the benchmark for predicting future staffing
needs locally. Detailed measurements of how long each proce-
dure or activity takes to perform is probably the most objective
basic evidence required to estimate full-time equivalent staffing
levels (20). Such measurements are logically more useful and
valid if they are performed in a variety of clinics, for a range
of services and applied to professionals with a wide range of
experience.
ACCESS
The concept of access (or accessibility) to radiotherapy services
refers to the fact that these medical services can be utilized by all
patients who need them. Access includes availability, accessibility,
affordability, accommodation, and awareness of health profession-
als and the public. The existence of radiotherapy departments or
services in a country (availability) is a necessary but not sufficient
condition for access. For example, a clinic may be geographically
inaccessible to patients residing in another region of the country.
Or a majority of available clinics in a given country may be private
clinics demanding payment for service, which makes them inac-
cessible to a significant sector of the population below the poverty
level. It is the government’s responsibility through its ministry
of health to ensure access to radiotherapy services to all cancer
patients who need them.
QUALITY AND SUSTAINABILITY
Quality in radiotherapy means providing a service that satisfies
patient’s expectations follows optimal professional practice by
obtaining optimal results and fulfils the regulatory requirements
at a minimal cost and without waste of resources. Thus, quality in
radiotherapy has different meanings from the perspective of the
patient, the professional, or the administrator.
The concept of total quality management (TQM) consists of
organization-wide efforts to install and make permanent a cli-
mate in which an organization continuously improves its ability
to deliver high-quality products or services to customers, has been
borrowed from the industry, particularly from the standardized
approach to quality called ISO (21). It is a set of control points
that ensures that each element of a process or a series of processes
conforms to a pre-established standard. The idea behind it is that
if a process conforms to its standards, then the result will actually
meet the expectations. In radiotherapy, the expectations are the
control of a cancer with minimal and predictable negative impact
on quality-of-life.
Quality can be assessed by three different approaches (22): by
the infrastructure, processes, or outcomes.
Infrastructure: the rationale is that quality can only be produced
within an appropriate infrastructure (buildings, staffing, compe-
tences and equipment). Process: a second approach is process
control. It is based on the observation that if a process conforms
to a standard, then the quality of its results is predictable. Out-
comes: the ultimate goal of radiotherapy, as mentioned earlier, is
disease control. Five-year survival, years of survival adjusted for
quality-of-life (“quality-adjusted life years”; QUALY), local con-
trol, and other clinical endpoints are all legitimate measurements
of the appropriateness of radiotherapy interventions.
To assess quality in countries with established services, it
is recommended to conduct an annual survey of production,
equipment, and personnel of radiotherapy centers. This should
include questions on the number and type of external beam and
brachytherapy treatment equipment, absolute number, and num-
ber of full-time equivalent radiation oncologists, medical physi-
cists, and radiation technologists and support personnel number
of persons in training and vacancies. It is also advisable to select a
set of validated quality indicators and apply this set year after year
to document the dynamics of the radiotherapy system as a whole.
Budgetary provisions must be set aside for the maintenance
of equipment, maintenance service and repairs, replacement of
parts and sources, overheads and consumables and training and
education of staff.
Radiotherapy services should be patient-centered. This means
that the facilities should offer convenience for the patients and
families, and patient’s priorities and needs are respected. Main
aspects of the service that are important to patients include: receiv-
ing the highest level of medical care, a reduction of the waiting time
between diagnosis and treatment, appropriate communication
with medical and other healthcare staff, obtaining information
about their condition and its treatment and convenience of
access.
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Avoiding excessive waiting time (more than 14 days) and wait-
ing lists is particularly important. Excessive waiting time for radio-
therapy increases the risk of local tumor recurrence and eventual
treatment failure (23). Waiting lists for radiotherapy are a highly
visible indicator of the inability of the healthcare system to provide
the service needed. Patients and families are understandably very
sensitive to this problem. They may approach the media. In sev-
eral countries, the direct intervention of government even through
specific normative has resulted in the reduction or elimination of
waiting lists.
CONCLUSION
Obstacles to the effectiveness and efficiency of radiotherapy ser-
vices at country level include: (1) the lack of a network type orga-
nizational structure that would link radiotherapy centers in such
a way that it ensures access to a wide range of radiotherapy tech-
niques available, (2) a limited quality management culture with
services oriented to the professionals more than to the patients,
(3) work organization oriented to the day-to-day practice rather
than a medium or long-term strategic planning, and (4) lack of
a system of self-evaluation based on carefully recorded clinical
outcomes.
Observation and analysis of radiotherapy services planning
around the world show that the optimal provision and outcomes
are reached when (1) radiotherapy services are centrally planned
and monitored through the continued use of validated indicators
over time, (2) radiotherapy services are integrated into national
cancer control plans, (3) local problems of access to radiotherapy
services are systematically identified and addressed, (4) radiother-
apy services are given the necessary attention through a combi-
nation of political will tapping into resources from government,
international organizations and NGOs.
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